Executive Profile

Robert J. More General Partner, Frazier Healthcare Ventures

Age	Total Calculated Compensation	This person is connected to 7 Board Members in 7 different organizations across 18 different industries. See Board Relationships
--	--

Background

Dr. Robert J. More, Bob, serves as the Chief Operating Officer of Morphochem, Inc. Dr. More serves as a General Partner of Frazier Healthcare Ventures. He joined the Frazier in 2008. Dr. More serves as Secretary of NovaCardia, Inc. He serves as a Venture Capital Advisor at Okapi Venture Capital, LLC. He serves as a Member of the Frazier Healthcare Ventures biopharma and medical device investment teams. He looks into the Frazier Healthcare Ventures investments in Glaukos ... Corporation, Nuon Pharmaceuticals, Oceana, and was previously responsible for investments in ESP Pharma, Proxima Therapeutics, Onux Medical, NovaCardia, Esprit Pharma and IntraLase. He served as a Partner at Domain Associates, LLC, where his deals include ESP Pharma (acquired by Protein Design Labs), Proxima Therapeutics (acquired by Cytyc), Onux Medical (acquired by C.R. Bard), NovaCardia (acquired by Merck), Esprit Pharma (acquired by Allergan) and IntraLase (acquired by Advanced Medical Optics. He joined the Domain Associates, LLC as a Kauffman Fellow in 1996 and became a Partner in 2000. He was responsible for the investment in IntraLase. Previously, he served as the Chief Operating Officer of Small Molecule Therapeutics from 1997 to 1998. From 1992 to 1995, he served at Pharmacia Biotech AB as a Senior Sales Associate. Prior to joining Pharmacia, He held a research position at Somatogen. During business school, he worked with MedVest. He served as the Chairman at Novalar Pharmaceuticals, Inc. He serves as Director of Achaogen, Inc., Moximed, Inc. and Oceana Therapeutics, Inc. He served as a Director at Clovis Oncology, Inc. He serves as a Director of Acureon Pharmaceuticals, Inc., Evoke Pharma, Lipothera, Glaukos Corporation, NovaCardia, Inc., TargetRx, Inc., Windward Medical, and APNEX Medical, Inc. He serves as a Director of The Sulpizio Family Cardiovascular Center. He serves as a Member of Industry Advisory Board at Greenspring Associates, Inc., Montagu Newhall Associates, Inc. and The Medical Industry Group of the NVCA. He serves as a Member of Advisory Board of Fresh Tracks Capital and the Medical Industry Group and NVCA. He served as a Director of Lithera, Inc., Nuon Therapeutics, Inc., Apnex Medical, Inc., OmniSonics Medical Technologies, Inc., Novalar Pharmaceuticals, Receptor BioLogix Inc. and Auxeris Therapeutics, Inc. He served as a Director of Cytyc Surgical Products II, Inc. since 2001 and Carticept Medical, Inc. He served as a Board Member at The Center for Venture Education. He served as a Founding Board Member for Kauffman Fellows Program and his past Board memberships include ESP Pharma, Inc., Proxima Therapeutics, Onux Medical, Inc., Beansprout Networks, Inc., NovaCardia, Esprit Pharma and IntraLase. Dr. More received an MBA from the Darden School of Business Administration, University of Virginia in 1996 and a B.A. from Middlebury College in 1989.

Corporate Headquarters Two Union Square Seattle, Washington 98101 United States Phone: 206-621-7200 Fax: 206-621-1848 Board Members Memberships Director Beansprout Networks, Inc. Former Director Onux Medical, Inc. Director PatientKeeper, Inc. Former Director OmniSonics Medical Technologies, Inc. Director TargetRx, Inc. Former Member of the Board of Directors ESP Pharma, Inc. Former Chairman Novalar Pharmaceuticals, Inc. Director Glaukos Corporation Secretary NovaCardia, Inc. Director Auxeris Therapeutics, Inc. Former Director Receptor BioLogix, Inc. Director Achaogen, Inc. Director Carticept Medical, Inc. Director Center For Venture Education Director Acureon Pharmaceuticals, Inc. Former Director Apnex Medical, Inc. Director Nuon Therapeutics, Inc. Director Moximed, Inc. Director Oceana Therapeutics, Inc. Former Director Lithera, Inc. Former Director Clovis Oncology, Inc. Director UC San Diego Sulpizio Cardiovascular Center 2001-N/A Director Cytyc Sugical Products II, Limited Partnership Education BA 1989 Middlebury College MBA 1996 Colgate W. Darden Graduate School of Business Administration Other Affiliations Domain Associates, L.L.C. Beansprout Networks, Inc. Onux Medical, Inc. Cytyc Sugical Products II, Limited Partnership Morphochem, Inc. Baxter Hemoglobin Therapeutics, Inc. PatientKeeper, Inc. OmniSonics Medical Technologies, Inc. TargetRx, Inc. Pharmacia Biotech AB Greenspring Associates, Inc. ESP Pharma, Inc. Novalar Pharmaceuticals, Inc. Glaukos Corporation NovaCardia, Inc. Auxeris Therapeutics, Inc. University of Virginia Middlebury College Receptor BioLogix, Inc. Colgate W. Darden Graduate School of Business Administration Achaogen, Inc. Carticept Medical, Inc. Okapi Venture Capital, LLC Center For Venture Education Acureon Pharmaceuticals, Inc. Apnex Medical, Inc. Nuon Therapeutics, Inc. Moximed, Inc. Oceana Therapeutics, Inc. Lithera, Inc. Clovis Oncology, Inc. UC San Diego Sulpizio Cardiovascular Center

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.